Frontiers in superbug management: innovating approaches to combat antimicrobial resistance

Area of Science:

• Microbiology
• Infectious Diseases
• Biotechnology

Background:

• Antimicrobial resistance (AMR) presents a significant global health challenge, leading to increased mortality and economic strain.
• The decline in new antibiotic development and the rise of multidrug-resistant (MDR) pathogens, or
• superbugs
• exacerbate the AMR crisis, threatening common infections and medical procedures.
• AMR undermines decades of progress in infectious disease control.

Purpose of the Study:

• To review the global spread, mechanisms, and drivers of AMR.
• To explore innovative methodologies for identifying resistant strains and combating AMR.
• To provide a comprehensive overview of AMR, including epidemiology, control, and emerging therapies.

Main Methods:

• Literature review of global AMR proliferation, mechanisms, and contributing factors.
• Examination of advanced techniques including CRISPR/Cas9, nanoparticle technology, light-based methods, and AI-powered antibiogram analysis.
• Analysis of challenges in implementing AI-based diagnostics in resource-limited settings.

Main Results:

• CRISPR/Cas9 offers precise DNA targeting for combating MDR bacteria, surpassing traditional methods.
• Light-based antimicrobial techniques show promise for killing resistant microbes and treating localized infections.
• AI-driven antibiogram analysis via smartphones presents potential but faces infrastructure and technical hurdles.

Conclusions:

• Novel therapeutic approaches beyond traditional antibiotics are crucial for addressing the AMR crisis.
• Technological advancements like CRISPR/Cas9 and AI offer promising avenues for AMR surveillance and treatment.
• Effective AMR control requires a multifaceted strategy encompassing prevention, stewardship, surveillance, and innovative non-antibiotic therapies.